Citations

Clear

6273 citation(s) found for "To, Andrew".

The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults
Amer, Hatem , Cornell, Lynn D. , Taler, Sandra J. , Cosio, Fernando G., Kremers, Walter K. , Textor, Stephen C., Stegall, Mark D. , Rule, Andrew D. , Stegall, Mark D , Amer, Hatem , Cornell, Lynn , Kremers, Walter K

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 152 | Issue: 9 | Pages: 561-567

10.7326/0003-4819-152-9-201005040-00006 | PMID 20439574 Get It

Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease
Larson, Timothy S., Bergstralh, Erik J., Jacobsen, Steven J. , Cosio, Fernando G., Rule, Andrew D. , Slezak, Jeff M.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 141 | Issue: 12 | Pages: 929-937

10.7326/0003-4819-141-12-200412210-00009 | PMID 15611490 Get It

A Clinical Study of Duodenitis, Gastritis and Gastrojejunitis
Rivers, Andrew B.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 4 | Issue: 10 | Pages: 1265-1281

10.7326/0003-4819-4-10-1265 Get It

The Effect of Cholecystectomy On Gastric Acidity
HARTMAN, HOWARD R., Rivers, Andrew B.

Mayo Clinic

Annals of Internal Medicine | April 11, 2013 | Volume: 1 | Issue: 8 | Pages: 558-562

10.7326/0003-4819-1-8-558 Get It

Surgical prevention of stroke
Moore, Wesley S. , Brott, Thomas G. , Barleben, Andrew R.

Mayo Clinic

Stroke Management and Recovery | April 10, 2013 | Volume: No volume available | Issue: No issue available | Pages: 100-113

10.2217/ebo.12.460 Get It

Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
Davies, Paul , Hinkle, Kelly M., Sukar, Nour N., Sepulveda, Bryan, Mesias, Roxana , Alessi, Dario R. , Beach, Thomas G. , Benson, Deanna L. , White, Charles L. , Cowell, Rita M. , Das, Sonal S., West, Andrew B. , Melrose, Heather L. , Serrano, Geidy E. , White, Charles L , Alessi, Dario R

Mayo Clinic

Biochemical Journal | April 9, 2013 | Volume: 453 | Issue: 1 | Pages: 101-113

10.1042/bj20121742 | PMID 23560750 Get It

Missense mutations in LRRK2 (leucine-rich repeat kinase 2) are a major cause of PD (Parkinson's disease). Several antibodies against LRRK2 have been developed, but results using these polyclonal antibodies have varied widely leading to conflicting conclusions. To address this challenge, the Michael J. Fox Foundation for Parkinson's Research generated a number of monoclonal antibodies targeting epitopes across the LRRK2 protein. In the present paper, we report optimized protocols and results for ten monoclonal antibodies for immunoblotting, immunohistochemistry, immunoprecipitation and kinase activity assays, in rat, mouse and human brain tissue. Several efficacious antibodies were identified, but results demonstrate that the mouse monoclonal N241A/34 is suitable for most applications, with the best overall rabbit monoclonal antibody being c41-2. These antibodies produced a dominant band of the expected size via immunoblotting and a lack of labelling in tissue derived from LRRK2-knockout animals under optimized conditions. A significant proportion of LRRK2 protein localizes to insoluble fractions and no evidence of truncated LRRK2 protein was detected in any fraction from rodent or human tissues. An assay was developed for the robust detection of LRRK2 kinase activity directly from frozen mouse and human brain tissue, but precipitous declines in activity were observed that corresponded to increasing post-mortem intervals and processing times. Finally, we demonstrate the highest levels of brain-localized LRRK2 in the striatum, but note differential expression patterns between rat and mouse in both striatum and cortex. Anti-LRRK2 monoclonal antibodies that are unlimited in availability together with the proposed standardized protocols should aid in the definition of LRRK2 function in both health and disease.
Characterization of the Pneumocystis carinii Histone Acetyltransferase Chaperone Proteins PcAsf1 and PcVps75
Pupaibool, Jakrapun , Bouchonville, Kelly J. , Kottom, Theodore J. , Limper, Andrew H. , Pupaibool, Jakrapun

Mayo Clinic

Infection and Immunity | April 9, 2013 | Volume: 81 | Issue: 6 | Pages: 2268-2275

10.1128/iai.01173-12 | PMID 23569117 Get It

ABSTRACT Rtt109 is a lysine acetyltransferase that acetylates histone H3 at lysine 56 (H3K56) in fungi. This acetylation event is important for proper DNA replication and repair to occur. Efficient Rtt109 acetyltransferase activity also requires a histone chaperone, vacuolar protein sorting 75 (Vps75), as well as the major chaperone of the H3-H4 dimer, anti-silencing factor 1 (Asf1). Little is known about the role of these proteins in the opportunistic fungal pathogen Pneumocystis carinii . To investigate the functions of Asf1 and Vps75 in Pneumocystis carinii , we cloned and characterized both of these genes. Here, we demonstrate that both genes, P. carinii asf1 ( Pcasf1 ) and Pcvps75 , function in a fashion analogous to their Saccharomyces cerevisiae counterparts. We demonstrate that both P. carinii Asf1 (PcAsf1) and PcVps75 can bind histones. Furthermore, when Pcasf1 is expressed heterologously in S. cerevisiae asf1 Δ cells, PcAsf1 can restore full H3 lysine acetylation. We further demonstrated that the Pcasf1 cDNA expressed in asf1 Δ S. cerevisiae cells can restore growth to wild-type levels in the presence of genotoxic agents that block DNA replication. Lastly, we observed that purified PcAsf1 and PcVps75 proteins enhance the ability of PcRtt109 to acetylate histone H3-H4 tetramers. Together, our results indicate that the functions of the Rtt109-Asf1-Vps75 complex in the acetylation of histone H3 lysine 56 and in DNA damage response are present in P. carinii DNA and cell cycle progression.
Tissue Localization of Transforming Growth Factor-Beta1 in Pulmonary Eosinophilic Granuloma
Asakura, S, Colby, Thomas V. , Limper, Andrew H.

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 154 | Issue: 5 | Pages: 1525-1530

10.1164/ajrccm.154.5.8912775 | PMID 8912775 Get It

Abstract Pulmonary eosinophilic granuloma is characterized by infiltration of the lungs with fibronodular lesions containing specialized Langerhans' cells. In some patients, progressive pulmonary fibrosis leads to significant respiratory impairment. Transforming growth factor-beta1 (TGF-beta1) promotes fibrosis by enhancing the synthesis of extracellular matrix components. The role of TGF-beta1 in promoting fibrosis in the setting of pulmonary eosinophilic granuloma is currently unknown. We used immunohistochemistry to evaluate the extent and distribution of TGF-beta1 and the extracellular matrix components type I collagen and decorin, a TGF-beta1-binding proteoglycan. Lung biopsies from 11 patients with pulmonary eosinophilic granuloma were evaluated. In biopsies with active inflammatory lesions containing Langerhans' cells, hyperplastic type 2 pneumocytes and alveolar macrophages within and surrounding the fibronodular lesions contained abundant TGF-beta1. Langerhans' cells were consistently devoid of immunoreactive TGF-beta1. Active inflammatory lesions also exhibited staining for decorin, in a loosely organized distribution. Advanced fibrotic lesions of eosinophilic granuloma, containing minimal inflammatory cells and few or no Langerhans' cells, exhibited weak or absent staining for TGF-beta1 within either hyperplastic type 2 pneumocytes or alveolar macrophages. The fibroconnective tissues of these advanced fibrotic lesions consistently revealed dense staining for decorin. Through their actions on extracellular matrix protein accumulation, TGF-beta1 and the TGF-beta1-binding proteoglycan decorin may modulate fibrotic repair accompanying pulmonary eosinophilic granuloma.
Acute Eosinophilic Pneumonia: Histopathologic Findings in Nine Patients
Tazelaar, Henry D. , Lin-z, Long, Colby, Thomas V. , Tazelaar, Henry D. , Myers, Jeffrey L. , Limper, Andrew H.

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 155 | Issue: 1 | Pages: 296-302

10.1164/ajrccm.155.1.9001328 | PMID 9001328 Get It

Abstract Acute eosinophilic pneumonia is characterized by acute respiratory insufficiency, hypoxemia, fever, diffuse radiographic infiltrates, and eosinophilia in bronchoalveolar lavage fluid (BALF) or lung biopsies in the absence of infection, atopy, or asthma. A rapid response to corticosteroids is characteristic. We reviewed our experience with nine cases of acute lung disease with histologic features of acute and organizing diffuse alveolar damage and prominent interstitial and alveolar eosinophils in order to determine whether this pathology was characteristic of acute eosinophilic pneumonia. The mean age of the patients (four men and five women) was 53 yr (range: 33 to 71 yr). They presented with 2 to 21 d of dyspnea, cough, myalgias, and fever. All were hypoxic and had bilateral infiltrates on chest radiographs. Peripheral blood eosinophilia was present in four of eight patients (peripheral blood count unavailable for one patient). All patients were treated with high-dose corticosteroids with a mean time to symptomatic and radiographic improvement of 4 d. Seven of the nine patients enrolled in the study are alive without relapse; one patient has a mild deficit in diffusing capacity, and one patient died of a myocardial infarct while improving on therapy. The presence of eosinophils in cases of acute respiratory insufficiency due to diffuse alveolar damage (DAD) should suggest the diagnostic possibility of acute eosinophilic pneumonia. Acute eosinophilic pneumonia should be distinguished from other causes of DAD because of important differences in natural history.